舌下含服尘螨滴剂联合盐酸西替利嗪滴剂、氮卓斯汀喷鼻在小儿变应性鼻炎中的治疗效果

doi:10.3760/cma.j.issn.1007-1245.2022.23.011

摘要/Abstract

摘要： 目的　探讨尘螨滴剂联合西替利嗪、氮卓斯汀治疗小儿变应性鼻炎（AR）的临床价值。方法　选取2020年6月至2022年3月焦作市妇幼保健院160例AR患儿，根据治疗方案差异分为对照组（80例，接受西替利嗪治疗）和研究组（80例，接受西替利嗪联合舌下含服尘螨滴剂治疗），疗程均为2个月。对比两组症状改善时间，治疗前后的C反应蛋白（CRP）、免疫球蛋白A、E、M（IgA、IgE、IgM）、白细胞介素6（IL-6）水平及不良反应。统计学方法采用t检验、χ²检验。结果　治疗后患儿症状改善情况：研究组患儿鼻塞、流涕、鼻痒、喷嚏改善时间均短于对照组（t=9.792、5.810、5.737、4.969，均P<0.05）；两组治疗前后免疫因子对比：治疗前两组IgM、IgA、IgE，差异均无统计学意义（t=0.714、0.529、0.474，均P>0.05），治疗后研究组IgM、IgA、IgE水平均低于对照组，差异均有统计学意义（t=2.879、5.464、0.584，均P<0.05）；治疗前研究组与对照组CRP［（8.13±0.95）mg/L比（8.03±0.89）mg/L］、IL-6［（36.47±10.97）pg/ml比（30.52±6.23）pg/ml］对比，差异均无统计学意义（t=0.518、0.026，均P>0.05），治疗后研究组的CRP、IL-6均低于对照组，差异均有统计学意义（t=13.871、4.912，均P<0.05）；两组总不良反应率对比：对照组总不良反应率为11.25%（9/80），研究组总不良反应率为10.00%（8/80），差异无统计学意义（χ²=0.066，P=0.798）。结论　尘螨滴剂联合盐酸西替利嗪、氮卓斯汀治疗可有效缩短AR患儿症状改善时间，改善患儿血清炎性因子及免疫因子水平。

关键词: 过敏性鼻炎, 儿童, 尘螨滴剂, 西替利嗪, 氮卓斯汀, 免疫功能

Abstract: Objective　To investigate the clinical value of dust mite drops combined with cetirizine and azelastine in the treatment of children with allergic rhinitis (AR). Methods　One hundred and sixty children with AR treated at Jiaozuo Maternal and Child Health Hospital from June 2020 to March 2022 were selected. According to the treatment schemes, they were divided into a control group, treated by cetirizine, and a study group, treated by cetirizine and sublingual dust mite drops, with 80 cases in each group. Both groups were treated for 2 months. The symptom improvement times, the levels of C-reactive protein (CRP), immunoglobulin A, E, and M (IgA, IgE, and IgM), and interleukin-6 (IL-6) before and after the treatment, and adverse reactions were compared between the two groups.t and χ² tests were applied. Results　The improvement times of nasal congestion , runny nose , nasal itching , and sneezing in the study group were shorter than those in the control group (t=9.792, 5.810, 5.737, and 4.969;all P<0.05). Before the treatment, there were no statistical differences in IgM , IgA , and IgE between the two groups (t=0.714, 0.529, and 0.474; all P>0.05). After the treatment, the levels of IgM , IgA , and IgE in the study group were lower than those in the control group, with statistical differences (t=2.879, 5.464, and 0.584;all P<0.05). Before the treatment, there no statistical differences in CRP [(8.13±0.95)mg/L vs. (8.03±0.89)mg/L] and IL-6 [(36.47±10.97) pg/ml vs. (30.52±6.23)pg/ml] between the study group and the control group, with no statistical differences (t=0.518 and 0.026; both P<0.05). After the treatment, the levels of CRP and IL-6 in the study group were lower than those in the control group, with significant differences (t=13.871 and 4.912; both P<0.05). The total incidence of adverse reactions was 11.25%(9/80) in the control group, and was 10.00%(8/80) in the study group, with no statistical difference （χ²=0.066， P=0.798). Conclusion　Dust mite drops combined with cetirizine hydrochloride and azelastine can effectively shorten the time of symptom improvement in children with AR, and improve the levels of serum inflammatory factors and immune factors.

Key words: Allergic rhinitis, Children, Dust mite drops, Cetirizine, Azelastine, Immune function

秦欠欠廉用成. 舌下含服尘螨滴剂联合盐酸西替利嗪滴剂、氮卓斯汀喷鼻在小儿变应性鼻炎中的治疗效果[J]. 国际医药卫生导报, 2022, 28(23): 3300-.

Qin Qianqian, Lian Yongcheng. Sublingual dust mite drops combined with cetirizine hydrochloride drops and azelastine nasal spray in treatment of children with allergic rhinitis[J]. International Medicine and Health Guidance News, 2022, 28(23): 3300-.

参考文献

[1] 栗向韶,王湘,沈晓伟,等.盐酸氮卓斯汀鼻喷剂与地氯雷他定联合治疗过敏性鼻炎的疗效观察[J].中国医药科学,2018,8(24):29-31,82.DOI:10.3969/j.issn.2095-0616. 2018.24.008.
[2] 邹杨,余海波,唐成忠.丙酸氟替卡松气雾剂联合西替利嗪治疗小儿季节性过敏性鼻炎的临床效果[J].西部医学,2019,31(3):443-446.DOI:10.3969/j.issn.1672-3511. 2019.03.024.
[3] 谢骏,赵斯君,陈飞翔,等.尘螨滴剂治疗儿童过敏性鼻炎的临床效果及对患儿机体免疫功能影响的研究[J].国际耳鼻咽喉头颈外科杂志,2021,45(3):125-129.DOI:10.3760/cma.j.issn.1673-4106.2021.03.001.
[4] 中华耳鼻咽喉头颈外科杂志编委会,中华医学会耳鼻咽喉头颈外科学分会鼻科学组.变应性鼻炎诊断和治疗指南[J].中国临床医生,2010,38(6):67-68.DOI:10.3969/j.issn.1008-1089.2010.06.028.
[5] 韩加辉,张书嘉,董春光.千柏鼻炎片联合丙酸氟替卡松治疗过敏性鼻炎的临床研究[J].现代药物与临床,2020,35(3):521-524.DOI:10.7501/j.issn.1674-5515.2020.03.027.
[6] 杨一兵,李欣,王秦,等.大气PM2.5暴露对太原市过敏性鼻炎患者氧化应激水平的影响[J].中华预防医学杂志,2019,53(1):64-70.DOI:10.3760/cma.j.issn.0253-9624.2019. 01.008.
[7] 谢江,赵斯君,敬云龙,等.穴位敷贴联合抗组胺药对过敏性鼻炎患儿的临床疗效[J].中国医师杂志,2021,23(7):1104-1107.DOI:10.3760/cma.j.cn431274-20210105- 00012.
[8] 薛建荣,马敬,邱昌余,等.362例变应性鼻炎患者屋尘螨皮下免疫治疗全身不良反应的观察分析[J].中华耳鼻咽喉头颈外科杂志,2020,55(5):445-451.DOI:10.3760/cma.j.cn115330-20200426-00333.
[9] 宋小云,张俊杰.舌下免疫治疗对变应性鼻炎患者炎症因子及自噬的影响[J].临床耳鼻咽喉头颈外科杂志,2020,34(3):230-234.DOI:10.13201/j.issn.2096-7993.2020.03.011.
[10] 刘怡君,曾邦兵,曾浪.氯雷他定联合孟鲁司特钠对变应性鼻炎患者血清ICAM-1ECP EOS CSF的影响研究[J].河北医学,2019,25(2):280-284.DOI:10.3969/j.issn.1006-6233. 2019.02.028.
[11] 闫晶晶.舌下含服粉尘螨滴剂联合氯雷他定治疗儿童过敏性哮喘伴变应性鼻炎的疗效及机制[J].临床与病理杂志,2019,39(7):1441-1447.DOI:10.3978/j.issn.2095-6959. 2019.07.009.
[12] 邹佩汐,赵真,胡京华,等.舌下含服粉尘螨滴剂对不同年龄段过敏性鼻炎患者的临床疗效评估[J].中国临床医学,2020,27(2):269-273.DOI:10.12025/j.issn.1008-6358. 2020. 20192093.
[13] 刘伟昌,马秀丽,刘虎,等.直肠双氯芬酸联合舌下含服硝酸甘油预防ERCP术后胰腺炎的临床效果[J].国际医药卫生导报,2020,26(24):3746-3749.DOI:10.3760/cma.j.issn. 1007-1245.2020.24.008.

[1]	张娜, 魏伟, 许新科, 陈程, 孙贵芳, 谭永红. 儿童脑肿瘤切除术中大出血的危险因素分析[J]. 国际医药卫生导报, 2022, 28(8): 1099-1103.
[2]	索敬钧, 杨青彦, 李涛, 韩健乐, 杨俊伟, 王长安, 杨帅平. 含西罗莫司的四联免疫抑制剂方案对肾移植术后患者肾功能、T淋巴细胞亚群及预后的影响[J]. 国际医药卫生导报, 2022, 28(6): 752-755.
[3]	彭红, 陶莉, 顾静, 何娟, 唐梅. 分级心理护理干预体系改善儿童青少年住院患者焦虑抑郁情绪的应用效果分析[J]. 国际医药卫生导报, 2022, 28(6): 773-776.
[4]	冯睿杰, 李晓泽. 山西省长治市5 938例儿童呼吸道病原菌感染流行病学和病原学特征分析 [J]. 国际医药卫生导报, 2022, 28(6): 793-799.
[5]	田杰, 金玉, 刘素琴. 儿童塑型性支气管炎研究进展[J]. 国际医药卫生导报, 2022, 28(6): 805-808.
[6]	吴满红, 徐宁, 常燕群, 温健, 余楚岚, 黄双苗, 冯嘉欣, 邓海茵. 孤独症谱系障碍漏误诊56例分析[J]. 国际医药卫生导报, 2022, 28(6): 811-814.
[7]	张冰, 刘力. 生物制剂治疗儿童风湿性疾病的进展 [J]. 国际医药卫生导报, 2022, 28(6): 822-824.
[8]	曾莹吟, 翁蔚宗, 蔡铁良, 林志琼, 刘珊珊, 邓小明. 组合式吸入麻醉诱导装置在急诊儿童肱骨髁上骨折手法复位中的应用及其效果分析[J]. 国际医药卫生导报, 2022, 28(5): 606-611.
[9]	杨振娇柳春华衣明纪. 孤独症谱系障碍患儿的执行功能特征和影响因素[J]. 国际医药卫生导报, 2022, 28(24): 3505-.
[10]	王艳超. 注射用艾普拉唑钠对消化性溃疡伴出血的临床治疗效果[J]. 国际医药卫生导报, 2022, 28(22): 3140-3143.
[11]	韦显高王照卿韦万勉饶远勇杨家林程勇蓝耿亮覃广央何永恒. 手术时机对儿童先天性拇指多指畸形手术的效果体会[J]. 国际医药卫生导报, 2022, 28(22): 3186-3188.
[12]	杜江涛李扬欧阳山丹刘炳震林珍. 替加环素联合头孢哌酮舒巴坦治疗ICU重度腹腔感染的效果[J]. 国际医药卫生导报, 2022, 28(21): 3077-3081.
[13]	翟敏. 肠道菌群失调与口腔疾病研究概述——以儿童龋齿为例[J]. 国际医药卫生导报, 2022, 28(20): 2955-2960.
[14]	刘永蛟王丽娜张新顺邢朝品贾秀红谢庆芝. 黄河三角洲地区儿童慢性胃炎、消化性溃疡致病危险因素分析[J]. 国际医药卫生导报, 2022, 28(18): 2542-2548.
[15]	黄艺文黄白沙岑龙李鹏乐盛麟. 儿童先天性肠系膜裂孔疝伴肠坏死1例[J]. 国际医药卫生导报, 2022, 28(18): 2614-2616.